Capital Performance Advisors LLP Dexcom Inc Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Dexcom Inc stock. As of the latest transaction made, Capital Performance Advisors LLP holds 69 shares of DXCM stock, worth $4,854. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69Holding current value
$4,854% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DXCM
# of Institutions
1,065Shares Held
361MCall Options Held
4.11MPut Options Held
3.61M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.27 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.43 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.15 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.08 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$840 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $27.2B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...